K2 Principal Fund’s AnaptysBio ANAB Stock Holding History

K2 Principal Fund’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-57,721	Closed	-$851K	–	314
2020 Q3	$851K	Buy	+57,721	New	+$1.04M	0.13%	162

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

K2 Principal Fund's ANAB Position: Q4 2020 in Review

K2 Principal Fund sold out of AnaptysBio (ANAB) in Q4 2020, closing a stake of 57,721 shares — an estimated $851K sold.

K2 Principal Fund first reported a position in ANAB in Q3 2020 and held it in 1 quarter. The position peaked at $851K in Q3 2020. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

K2 Principal Fund reported no remaining AnaptysBio position as of Q4 2020 after selling out during the quarter.
K2 Principal Fund sold 57,721 AnaptysBio shares in Q4 2020, an estimated $851K.
K2 Principal Fund first reported a position in AnaptysBio in Q3 2020 and held it in 1 quarter.
K2 Principal Fund's AnaptysBio position peaked at $851K in Q3 2020.
136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on K2 Principal Fund's 13F filing for Q4 2020, filed 12 Feb 2021.